类风湿关节炎的骨小梁与皮质骨受累:基于DXA和DXA三维建模的分析
横断面研究纳入105例类风湿关节炎(RA)患者和100名年龄、性别、BMI匹配的对照,用DXA及三维建模评估髋部骨小梁与皮质骨。RA患者股骨颈和全髋骨密度及骨小梁、皮质骨体积骨密度均显著低于对照;c-DMARD组显著低于对照,b-DMARD组多数参数与对照无显著差异。
要点
- RA患者股骨颈和全髋骨密度及骨小梁、皮质骨体积骨密度均显著低于对照。
- c-DMARD组(n=75)骨小梁和皮质骨体积骨密度显著低于对照。
- b-DMARD组(n=30)多数参数与对照无显著差异。
核心结论
- RA患者发生低骨密度或骨质疏松的风险高于对照。
- 接受c-DMARD治疗的RA患者骨密度显著低于对照,而接受b-DMARD治疗的患者与对照间多数参数无显著差异。
- 三维DXA分析可发现RA患者骨小梁和皮质骨骨 compartments 的改变。
研究设计与样本
- 横断面研究,纳入105例RA患者和100名按年龄、性别和BMI匹配的对照。
- 采用双能X线吸收测定法(DXA)测量双侧股骨颈和全髋骨密度,并用三维-Shaper软件对髋部扫描进行三维分析,包括骨小梁和皮质骨骨密度。
主要发现
- RA患者股骨颈和全髋骨密度及骨小梁和皮质骨体积骨密度均显著低于对照。
- c-DMARD组(n=75)骨小梁和皮质骨体积骨密度显著低于对照。
- b-DMARD组(n=30)尽管数值较低,多数参数与对照相比无显著差异。
- RA病程1至5年的组骨小梁和皮质骨三维参数显著低于对照;皮质类固醇治疗1至5年的组骨小梁体积骨密度显著低于对照,而同期标准DXA未发现显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Rheumatoid arthritis (RA) patients had a higher risk of developing low bone mineral density (BMD) or osteoporosis. RA patients on classic disease-modifying antirheumatic drug (c-DMARD) therapy showed significantly lower BMD than controls, while no significant differences in most parameters were found between RA patients receiving biological disease-modifying antirheumatic drugs (b-DMARDs) and controls. The 3D analysis allowed us to find changes in the trabecular and cortical compartments. INTRODUCTION: To evaluate cortical and trabecular bone involvement of the hip in RA patients by dual-energy X-ray absorptiometry (DXA) and 3D analysis. The secondary end-point was to evaluate bone involvement in patients treated with classic (c-DMARD) or biological (b-DMARD) disease-modifying antirheumatic drug therapies and the effect of the duration of the disease and corticosteroid therapy on 3D parameters. METHODS: A cross-sectional study of 105 RA patients and 100 subjects as a control group (CG) matched by age, sex, and BMI was carried out. BMD was measured by DXA of the bilateral femoral neck (FN) and total hip (TH). The 3D analyses including trabecular and cortical BMD were performed on hip scans with the 3D-Shaper software. RESULTS: FN and TH BMD and trabecular and cortical vBMD were significantly lower in RA patients. The c-DMARD (n = 75) group showed significantly lower trabecular and cortical vBMD than the CG. Despite the lower values, the b-DMARD group (n = 30) showed no significant differences in most parameters compared with the CG. The trabecular and cortical 3D parameters were significantly lower in the group with an RA disease duration of 1 to 5 years than in the CG, and the trabecular vBMD was significantly lower in the group with a duration of corticosteroid therapy of 1 to 5 years than in the CG, while no significant differences were found by standard DXA in the same period. CONCLUSIONS: RA patients had a higher risk of developing low BMD or osteoporosis than controls. RA patients receiving c-DMARD therapy showed significantly lower BMD than controls, while no significant differences in most parameters were found between RA patients receiving b-DMARDs and controls. 3D-DXA allowed us to find changes in trabecular and cortical bone compartments in RA patients.
引用
- Brance ML, Pons-Estel BA, Quagliato NJ, et al. Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modelling. Osteoporos Int. 2020. PMID: 32974730. doi:10.1007/s00198-020-05641-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。